Medtronic saw potential in CathWorks’ technology in 2018, becoming a minority investor with non-diluted funding before it was commercialized.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results